BioCentury

BioCentury This Week

Science EN ↓ 403 episodi

BioCentury's streaming commentary on biotech industry trends, plus interviews with KOLs. For three decades, BioCentury has helped biopharma executives and investors make business-critical decisions and build larger networks with peers across the innovation ecosystem.

Visita il sito del podcast e sostieni chi lo crea: www.biocentury.com

Autore

BioCentury

Categoria

Science

Sito del podcast

www.biocentury.com

Ultimo episodio

20 ott 2026

Dove ascoltare?

I podcast nell'app Replaio Radio In arrivo

I podcast stanno per arrivare nell'app. Installala ora e scopri per primo un modo tutto nuovo di vivere i podcast

Scaricala su Google Play Installala gratis Android quasi 10 mln di download · valutazione 4,8 iOS in arrivo

Episodi

Ep. 100 - Capital markets check in; plus Belgium’s prodigal son returns 01.02.2022

This week’s podcast is sponsored by ICON . Reach us by sending a text

Ep. 99 - Introducing The BioCentury Show, Plus Califf, COVID and GSK 25.01.2022

BioCentury’s new in-depth conversational series launches with Scott Gottlieb as debut guest. This week’s podcast is sponsored by ICON . Reach us by sending a text

Ep. 98 - Bargain Hunting in a Rocky Market, plus Advantage, CMS 19.01.2022

Part two of BioCentury’s 2022 Financial Markets Preview, access to Alzheimer’s mAbs, and translational highlights from the Distillery. This week’s podcast is sponsored by ICON . Reach us by sending a text

Ep. 97 - Buysiders' Picks, plus JPM22 roundup 11.01.2022

Reach us by sending a text

Ep. 96 - Aduhelm, Pazdur, Pharma Digital & '21 Wrap 21.12.2021

Reach us by sending a text

Ep. 95 - ASH's New Targets, Avistone & Washington Update 14.12.2021

Reach us by sending a text

Ep. 94 - Woodcock's To-Do List, Maraganore's Takeaways & the Distillery 07.12.2021

Reach us by sending a text

Ep. 93 - Omicron's Open Questions, Plus the Business Case for Ultra-rare Diseases 30.11.2021

Reach us by sending a text

Ep. 92 - Biogen’s R&D decision, previewing TIGIT & China Summit highlights 22.11.2021

Reach us by sending a text

Ep. 91 - China Summit Highlights: Day 2 18.11.2021

Reach us by sending a text

Ep. 90 - China Summit Highlights: Day 1 17.11.2021

Reach us by sending a text

Ep. 89 - Califf's Passions, RWE in China & LSP Rising 16.11.2021

Reach us by sending a text

Ep. 88 - China Summit Preview: The Bridge to Innovation 10.11.2021

Reach us by sending a text

Ep. 87 - Digesting Drug Pricing, Plus Access in ALS 09.11.2021

Reach us by sending a text

Ep. 86 - Woodcock's Legacy, Plus Frazier, Bain & the Distillery 02.11.2021

Reach us by sending a text

Ep. 85 - What's Next for CRISPR & Gene Therapy, Plus China Summit Preview 26.10.2021

Reach us by sending a text

Ep. 84 - Why Gene Therapy's Bad Year Is a Speed Bump, Not a Dead End 22.10.2021

Reach us by sending a text

Ep. 83 - Assessing Biogen’s ALS Miss, Plus Califf on Deck 18.10.2021

Reach us by sending a text

Ep. 82 - 4Q Markets Preview, Plus the Future of NIH 12.10.2021

Reach us by sending a text

Ep. 81 - Merck & the State of M&A, Plus Novartis CEO's Call to Action 05.10.2021

Reach us by sending a text

Ep. 80 - Hong Kong Rising, Plus Varmus' POV & Biden's FDA Choice 28.09.2021

Reach us by sending a text

Ep. 79 - ESMO, Jeito & the Latest from Washington 21.09.2021

Reach us by sending a text

Ep. 78 - Remembering Fred Frank, Lisa Raines, Plus CRISPR, Washington Updates 14.09.2021

Reach us by sending a text

Ep. 77 - Back to School Spotlight & Pressures on FDA 04.09.2021

Reach us by sending a text

Ep 76 Pt. 4 - Modifying Access for Accelerated Approvals 01.09.2021

Reach us by sending a text

Ascolta il podcast BioCentury This Week su Replaio

Radio e podcast in un'unica app - gratis e senza registrazione. Installala oggi e non perderti il lancio

Scaricala su Google Play

Replaio non è un editore di podcast; i nomi dei programmi, le copertine e l'audio appartengono ai rispettivi autori e vengono distribuiti tramite feed RSS pubblici